The International Contraceptive Access Foundation’s model for improving access to the hormonal intrauterine device
Document Type
Commentary
Publication Date
2-22-2025
Abstract
The International Contraceptive Access Foundation is a partnership between Bayer AG and Population Council Inc. with a mission to provide levonorgestrel-releasing intrauterine contraceptive systems at no charge to providers in low- and middle-income countries. For twenty years, the Foundation has enhanced knowledge of and access to this innovative contraceptive method. The Foundation has been critical to facilitating global access to hormonal intrauterine devices (IUDs). This Foundation model should be considered for the introduction of future methods of contraception.
Recommended Citation
Begg, Lorna, James Sailer, Kai Risse, Kendal Dannam, Joanna Holopainen, Milly Kaggwam, Anne Pfitzer, Saumya RamaRao, Juhani Syrjala, Nahla G. Abdel-Tawab, Marcel Van Valen, Maria Mercedes Vivas, Carolyn Westhoff, and Frank Strelow. 2025. "The International Contraceptive Access Foundation’s model for improving access to the hormonal intrauterine device," Contraception, https://doi.org/10.1016/j.contraception.2025.110854.
DOI
10.1016/j.contraception.2025.110854
Language
English
https://doi.org/10.1016/j.contraception.2025.110854